TY - JOUR T1 - Sensorimotor deficits in distance runners with medial plantar pain JF - medRxiv DO - 10.1101/2021.02.16.21251637 SP - 2021.02.16.21251637 AU - Colton Funk AU - John J. Fraser AU - Jacob Resch AU - Jay Hertel Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/02/19/2021.02.16.21251637.abstract N2 - Context Medial plantar pain is a complex and multifactorial condition experienced by some distance runners, which makes etiological differentiation and diagnosis challenging.Objective To assess plantar sensation, pain perception and sensitivity, intrinsic foot strength, and foot morphology before and after a 9.7 km run in long-distance runners with and without medial plantar pain.Design Descriptive laboratory studySetting Laboratory.Patients Seven distance runners with medial plantar pain (four males, three females; aged 22.3±3.7 years; BMI 22.3±3.5 kg/m2) and seven matched healthy controls (four males, three females; aged 20.3±1.0 years; BMI 22.0±1.7 kg/m2) were recruited from a public university.Intervention(s) Participants ran a six-mile course in their own footwear at a self-selected pace.Main Outcome Measures Pain visual analogue scale (VAS), pressure pain thresholds (PPT), plantar sensation, foot morphology, weight-bearing dorsiflexion (WBDF), forefoot joint mobility, toe flexion, intrinsic foot muscle strength, and a seated neural provocation test were analyzed pre-and post-run utilizing mixed model group by time ANOVAs, post hoc effect size point estimates, and 95% confidence intervals.Results A significant group by time interaction was observed for PPT at the mid-arch (Control: pre: 83.0±27.4N, post: 79.5±22.6N; Symptomatic: pre: 90.5±31.9N, post: 70.1±32.7 N; p=.03) and posterior tibialis (PT) (Control: pre: 75.7±19.5 N, post: 65.7±14.2N; Symptomatic: pre: 75.8±20.4 N, post: 51.1±11.9 N; p=.05) sites. PPT in the posterior tibialis significantly decreased in the symptomatic group following the run (ES=1.5, 95% CI: 0.3, 2.7). Both groups demonstrated significantly decreased plantar sensation thresholds at the base of the 5th metatarsal (p=.04), PPT at the calcaneal tuberosity (p=.001), and increased TMT extension (p=.01) and WBDF (p=.01) following the run.Conclusions The etiology of medial plantar pain observed in our sample was likely attributed to central sensitization and running-induced sensory changes. Clinicians should include sensorimotor testing when managing patients with medial plantar pain.Key Points Medial plantar pain is a unique pathologic entity that has not been previously well described and likely caused by central sensitization. Clinicians should include sensorimotor testing and interventions when managing patients with medial plantar pain.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis is a repeated-measures observational study assessing provocation of sensorimotor impairment before and following a 9.7 km run in long-distance runners with and without medial plantar pain.Funding StatementThis study was funded in part by the University of Virginia's Curry School of Education Foundation and the Navy Medicine Professional Development Center, US Navy Bureau of Medicine and Surgery.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All participants provided informed consent and this study was approved by the Institutional Review Board for Health Sciences Research at the University of Virginia in compliance with all applicable Federal regulations governing the protection of human subjects.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDue to the nature of this research, participants of this study did not agree for their data to be shared publicly, so supporting data is not available. ER -